Validation of an electronic algorithm for Hodgkin and non‐Hodgkin lymphoma in ICD‐10‐CM-Reference-Cited by-同舟云学术

Validation of an electronic algorithm for Hodgkin and non‐Hodgkin lymphoma in ICD‐10‐CM

Published:2021-05-05 Issue:7 Volume:30 Page:910-917
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Epstein Mara M.¹²^ORCID,Dutcher Sarah K.³^ORCID,Maro Judith C.⁴,Saphirak Cassandra¹²,DeLuccia Sandra⁴,Ramanathan Muthalagu⁵,Dhawale Tejaswini⁶,Harchandani Sonali⁵,Delude Christopher²,Hou Laura⁴,Gertz Autumn⁴,DiNunzio Nina⁴,McMahill‐Walraven Cheryl N.⁷,Selvan Mano S.⁸,Vigeant Justin⁴,Cole David V.⁴,Leishear Kira³,Gurwitz Jerry H.¹²,Andrade Susan¹²,Cocoros Noelle M.⁴^ORCID

Affiliation:

1. Division of Geriatric Medicine, Department of Medicine University of Massachusetts Medical School Worcester Massachusetts USA

2. The Meyers Primary Care Institute a joint endeavor of the University of Massachusetts Medical School, Reliant Medical Group, and Fallon Health Worcester MA USA

3. Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research Food and Drug Administration Silver Spring Maryland USA

4. Department of Population Medicine Harvard Pilgrim Health Care Institute, Harvard Medical School Boston Massachusetts USA

5. Division of Hematology and Oncology, Department of Medicine UMass Memorial Medical Center Worcester Massachusetts USA

6. Division of Medicine Massachusetts General Hospital Boston Massachusetts USA

7. Aetna, a CVS Health company Hartford Connecticut USA

8. Humana Healthcare Research, Inc. (HHR) Sugar Land Texas USA

Funder

National Center for Advancing Translational Sciences

U.S. Food and Drug Administration

Publisher

Wiley

Subject